期刊文献+

肺表面活性物质相关蛋白A基因多态性与儿童支原体肺炎易感性的研究 被引量:1

Surfactant protein A gene polymorphisms in child mycoplasma pneumonia
下载PDF
导出
摘要 目的探讨肺泡表面活性物质蛋白A(SP-A)基因多态性与儿童支原体肺炎发病风险的相关性。方法应用基因测序技术检测SP-A基因在100例支原体肺炎患儿及100例非支原体肺炎患儿中基因分布的频率;观察两组间基因型频率和等位基因频率的差异。结果病例组患儿100例的+186位点AA、AG、GG3种基因型的分布频率分别为73%、26%、1%,而对照组为61%、30%、9%,两组比较差异有统计学意义(P<0.05);+655位点CC、CT、TT基因型的分布频率分别为76%、23%、1%,对照组为52%、36%、12%,两组比较差异也有统计学意义(P<0.05);+667位点AA、AG、GG3种基因型的分布频率分别为28%、47%、25%,而对照组这3个基因基因型的分布频率分别为35%、51%、14%,两组比较差异无统计学意义(P>0.05)。结论 SP-A基因+186位点及+655位点基因多态性可能与儿童支原体肺炎易感性有关,但该位点的突变如何影响SP-A的表达和活性,还有待进一步的研究。 Objective To investigate the association between the surfactant protein A gene polymorphisms and child mycoplasma pneumonia.Methods Using gene sequencing technologies to test the surfactant protein A gene in 100 children with mycoplasma pneumonia(the infected group) and 100 cases without mycoplasma infections(the uninfected group) and to contrast the differences.Results In infected group the fequencies of +186 locus genotypes AA,AG and GG were 73%,26% and 1%,in the uninfected group these were 61%,30% and 9%.And the +655 locus genotypes CC,CT and TT were 76%,23% and 1%,in the uninfected group these were 52%,36% and 12%.There were statistically significant between two groups(P0.05).The frequency of polymorphic genotypes at +667 locus showd no statistical significance between two groups(P0.05).Conclusion SP-A gene polymorphisms at +186 locus and +655 locus may be connected with child mycoplasma pneumonia.
出处 《中国现代医药杂志》 2012年第11期35-37,共3页 Modern Medicine Journal of China
关键词 肺炎支原体肺炎 肺表面活性物质相关蛋白A 基因多态性 Mycoplasma pneumonia Surfactant protein A Gene polymorphisms
  • 相关文献

参考文献7

二级参考文献32

  • 1胡瑞成,徐永健,张珍祥.Surfactant Protein B 1580 Polymorphism Is Associated with Susceptibility to Chronic Obstructive Pulmonary Disease in Chinese Han Population[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2004,24(3):216-218. 被引量:13
  • 2曹玉璞.小儿肺炎支原体感染的诊断与治疗[J].中国实用儿科杂志,1995,10(6):339-340. 被引量:172
  • 3熊学琴,黄星原,刘智胜.小儿肺炎支原体中枢感染40例临床分析[J].武汉大学学报(医学版),2007,28(1):123-125. 被引量:12
  • 4McCormick SM,Boggaram V,Mendelson CR.Characterization of mRNA transcripts and organization of human SP-A1 and SPA2 genes[J].Am J Physiol, 1994,266: 354-366.
  • 5Hartshorn KL.Role of surfactant protein A and D (SP-A and SP-D) in human antiviral host defense[J].Front Biosci(Schol Ed),2010,2:527-546.
  • 6Paul O,Nkadi T,Allen Merritt M,et al.An Overview of Pulmonary Surfactant in the Neanate:Genetics,Metabolism,and the Role of Surfactant in Health and Disease[J].Mol Genet Metab,2009,97(2):95-101.
  • 7Wall A, Beers MF, Dodia C,et al.ATP and adenosine 3',5'-cyclic monophosphate stimulate the synthesis of surfactant protein A in rat lung[J].Am J Physiol, 1993,264:431-437.
  • 8Islam KN,Mendelson CR.Permissive effects of oxygen on cyclic AMP and interleukin-1 stimulation of surfactant protein A gene expression are mediated by epigenetic mechanisms[J].Mol Cell Biol,2006,26($): 2901-2912.
  • 9Floros J,Thomas NJ.Surfactant protein genetics in community-acquired pneumania:balancing the host inflammatory state[J].Crit Care,2011,15(2): 156.
  • 10Ledford JG,Eo B, Kislan MM,et al.Surfactant protein-A inhibits mycoplasma-induced dendritic cell maturation through regulation of HMGB-1 cytokine activity[J].J Immunol,2010,185(7):3884-3894.

共引文献76

同被引文献14

  • 1Hsia BJ, Ledford JG, Ports-Kant EN, et al. Mast cell TNF receptors regulate responses to Mycoplasma pneunwniae in surfaetant protein A (SP-A)-/-mice [J]. J Allergy Clin Immunol, 2012, 130(1):205-214.
  • 2Kandasamy P, Zarini S, Chart ED, et al. Pulmonary surfactant phos- phatidylglycerol inhibits Mycoplasma pneurnoniae-stdmulated eico- sanoid production from human and mouse macrophages [J]. J Biol Chem, 2011,286(10): 7841-7853.
  • 3Hermeyer K, Peters M, Briigmann M, et al. Demonstration of Myco- plasma bovis by immunohistoehemistry and in situ hybridization in an aborted bovine fetus and neonatal calf [J]. J Vet Diagn Invest, 2012, 24(2): 364-369.
  • 4Kim JH, Cho TS, Moon JH, et al. Serial changes in serum eosino- phil-associated mediators between atopic and non-atopie children af- ter Mycoplasma pneumoniae pneumonia [J]. Allergy Asthma Immu- nol Res, 2014, 6(5): 428-433.
  • 5Slain JE, Cheon BR, Shim JW, et al. Increased risk of refractory My- coplasma pnettmoniae pneumonia in children with atopic sensitiza- tion and asthma [J]. Korean J Pediatr, 2014, 57(6): 271-277.
  • 6Ruffini E, De Petris L, Candelotti P, et al. Lung abscess in a child secondary to Mycoplasma pneumoniae infection [J]. Pediatr Med Chir, 2014, 36(2): 87-89.
  • 7Sobieszezafska BM, Kasprzykowska U, Duda-Madej A, et al. Rele- vance of serology for Mycoplasma pneumoniae infection among chil- dren with persistent cough [J]. Adv Clin Exp Med, 2014, 23(2): 185-190.
  • 8Seo YH, Kim JS, Seo SC, et al. Predictive value of C-reactive pro- tein in response to macrolides in children with macrolide-resistant- Mycoplasma pneumoniae pneumonia [J]. Korean J Pediatr, 2014, 57 (4): 186-192.
  • 9Kristensen K, Nygaaxd U, S0rensen C. Clinical assessment cannot predict ff children are infected with Mycoplasma pneumoniae [J]. Ug- eskr Laeger, 2013, 175(48): 2949-2950.
  • 10李颖,张琪,孙春荣,李艳红,崔晓岱,刘明月.不同程度肺炎患儿血清肺表面活性蛋白A水平的变化[J].实用儿科临床杂志,2010,25(16):1243-1244. 被引量:7

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部